Press Releases

April 3, 2018

Prize bestowed to Dr. Zhijian “James” Chen for discovery of the cGAS enzyme and its DNA-sensing pathway and their impact on immune defense and autoimmune disease.

February 21, 2018

Datasets characterizing individual cells in rheumatoid arthritis and systemic lupus erythematosus disease tissue from the Accelerating Medicines Partnership for Rheumatoid Arthritis and Systemic Lupus Erythematosus (AMP RA/SLE) Phase I study are now available to the research community. Scientists from across the biomedical research community can access the AMP RA/SLE datasets to explore important research questions about these autoimmune conditions.

January 30, 2018

The National Institutes of Health is teaming with government, biopharmaceutical, life science and non-profit organizations to overcome obstacles and increase success for advancing promising treatments for Parkinson’s disease (PD). Part of the NIH Accelerating Medicines Partnership (AMP), AMP PD will focus on identifying and validating promising markers of disease called biomarkers that may be useful in tracking the progression of PD and could serve as biological targets for the development of new drugs.

January 23, 2018

The Foundation for the National Institutes of Health (FNIH) is pleased to open nominations for the inaugural Trailblazer Prize for Clinician-Scientists (Trailblazer Prize). This annual prize and $10,000 honorarium presented by the FNIH recognizes the outstanding contributions of early career clinician-scientists in the United States whose work has the potential to or has led to innovations in patient care. To nominate a colleague for this prize and learn about eligibility criteria, visit fnih.org/TrailblazerPrize. Nominations will be accepted through Friday, March 30 at 1:00 p.m. ET.

November 20, 2017

The Foundation for the National Institutes of Health (FNIH) is proud to announce that it received the Gold Stevie Award for Organization of the Year in the government/nonprofit category of the Women in Business Awards. The FNIH’s President and Executive Director, Maria C. Freire, Ph.D., also received a Gold Stevie Award for Woman of the Year in the government/non-profit category. 

October 12, 2017

The National Institutes of Health and 11 leading biopharmaceutical companies today launched the Partnership for Accelerating Cancer Therapies (PACT), a five-year public-private research collaboration totaling $215 million as part of the Cancer Moonshot. PACT will initially focus on efforts to identify, develop and validate robust biomarkers — standardized biological markers of disease and treatment response — to advance new immunotherapy treatments that harness the immune system to attack cancer. The partnership will be managed by the Foundation for the National Institutes of Health (FNIH), with the Food and Drug Administration serving in an advisory role.

September, 28 2017

The Foundation for the National Institutes of Health (FNIH) is proud to announce that President and Executive Director Maria C. Freire, Ph.D. has won a Washington Business Journal Women Who Mean Business Award. Now in its 14th year, this prestigious award honors the Washington, D.C. metropolitan area’s most influential business women across every industry and profession.

September 20, 2017

The Foundation for the National Institutes of Health (FNIH) is proud to recognize Richard J. Hodes, M.D., Director of the National Institute on Aging (NIA), an institute of the National Institutes of Health (NIH), and Eli Lilly & Company (Lilly) as recipients of the second annual Charles A. Sanders, M.D., Partnership Award.

May 9, 2017

The Board of Directors of the Foundation for the National Institutes of Health (FNIH) has unanimously elected Fred Seigel as a new member. Mr. Seigel is President and Chief Operating Officer of Beacon Capital Partners, a private real estate investment company based in Boston.

April 4, 2017

The Foundation for the National Institutes of Health (FNIH) has selected David M. Sabatini, M.D., Ph.D., to receive its fifth annual Lurie Prize in Biomedical Sciences for discovery of the mTOR (mechanistic target of rapamycin) cellular pathway as a key regulator of growth and metabolism in response to nutrients. Dr. Sabatini is a pioneer in the study of nutrient sensing and the impact of caloric restriction on health and lifespan. The Lurie Prize in Biomedical Sciences will be presented to Dr. Sabatini at the FNIH Award Ceremony hosted by CNN’s Wolf Blitzer on May 17 in Washington, D.C.